ESP vs PAMT

ESP presents a dichotomy of strong current profitability and concerning forward-looking indicators. While the Piotroski F-Score of 4/9 indicates stable financial health and margins remain robust, the company is facing a revenue contraction of -10.8% YoY. Most critically, management has explicitly warned in the 10-K that net income per share is expected to decline in fiscal 2026 due to higher costs in the existing backlog. With heavy insider selling and a technical trend score of 10/100, the stock appears overextended relative to its defensive Graham value of $38.77.

PAMT exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic year-over-year EPS decline of 369.2%. While the stock appears cheap on a Price-to-Book (0.94) and Price-to-Sales (0.33) basis, these metrics are overshadowed by negative operating margins (-29.82%) and shrinking revenues (-15.10%). The company has transitioned from a period of profitability (2021-2023) into a consistent loss-making cycle with significant earnings misses. The combination of deteriorating fundamentals and a 0/100 technical trend suggests a value trap rather than a value opportunity.